Updating On Novo Nordisk (NVO): Still Overvalued

My previous analysis on Novo Nordisk a few months back showed the company as overvalued and a HOLD. Following 5% drop in today's market, I still rate NVO stock as a hold. Click to know.

Related Keywords

Norway ,China ,Blackrock ,Nova Scotia ,Canada ,United States ,Norwegian ,Novo Victoza ,Eli Lilly ,Novo Nordisk ,Novo Nordisk Foundation ,Novo Nordisk Canada Inc ,Nordisk Sales ,Novo Nordisk Sales ,Nordisk Portfolio ,Novo Nordisk Portfolio ,Nordisk Insulin Portfolio ,Novo Nordisk Insulin Portfolio ,